The upregulation of XPO1 expression disrupts the balance of nucleoplasmic transport and leads to the mislocalisation of tumour suppressor proteins and oncoproteins (Table 1), which consequently promotes tumour progression and potentially fosters therapeutic resistance.81, 82, 83, 84, 85, 86, 87, 88. This evidence concerns the gene XPO1 and neoplasm.